Procodazole

This classification denotes a biological response modifier with the molecular formula C10H10N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) SG5IU7FD3R, chemically known as propionic acid, 2-(2-benzimidazolyl)- but more generally known as procodazole, which bears US NIH Compound Identifier 65708. European Medicines Agency schedules Procodazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10063MIG. The term PROCODAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). PROCODAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule procodazole under HS 29339990 and SITC 51577. As of Q4 2014, PROCODAZOLE remains US FDA's Preferred Term for this commodity. Procodazole bears US NLM identifiers UMLS ID C1882468 and NCI Concept Code C66472. SMILES: C1=CC=C2C(=C1)NC(=N2)CCC(=O)O.